Nicox is on track to file for approval of its NCX 470 therapy for eyesight-robbing disease glaucoma after it showed efficacy in a second pivotal trial. The positive data from the Phase 3 Denali trial ...
About NorthIsle Copper & Gold Inc. NorthIsle Copper & Gold, Inc. engages in the exploration, acquisition, and development of copper and other precious metal properties. It focuses on the North Island ...
NorthIsle Copper and Gold Inc., a junior resources company, engages in the exploration, development, and acquisition of mineral properties in Canada. The company explores for copper, gold, molybdenum, ...
SCZ.V Santacruz Silver Mining Ltd.
At close: 5 December at 4:00:00 pm GMT-5 ...
NCX 470 is currently enrolling patients in two multi-regional Phase 3 glaucoma clinical trials, Mont Blanc and Denali. The objective of these two trials is to demonstrate statistically superior IOP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback